Diverting the Diagnosis: A Case Report of Hemodialysis Masking the Etiology of Hyperammonemia.

IF 1.6 Q3 UROLOGY & NEPHROLOGY
Canadian Journal of Kidney Health and Disease Pub Date : 2025-06-11 eCollection Date: 2025-01-01 DOI:10.1177/20543581251347154
Adina Landsberg, Anukul Ghimire, Nicholas L Li, Tyrone G Harrison
{"title":"Diverting the Diagnosis: A Case Report of Hemodialysis Masking the Etiology of Hyperammonemia.","authors":"Adina Landsberg, Anukul Ghimire, Nicholas L Li, Tyrone G Harrison","doi":"10.1177/20543581251347154","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Hyperammonemia in patients receiving hemodialysis is uncommon but poses a significant clinical challenge due to the effective clearance of ammonia by dialysis, which can obscure the underlying cause. Recognizing atypical etiologies is crucial for appropriate management.</p><p><strong>Presenting concerns of the patient: </strong>A 59-year-old man being treated with hemodialysis presented with altered level of consciousness and recurrent hyperammonemia. Despite previous episodes of hyperammonemia, the etiology of his intermittently elevated ammonia remained unclear and was initially attributed to his kidney failure.</p><p><strong>Diagnoses: </strong>Initial assessments, including liver function tests, abdominal ultrasound, medication review, and genetic screening for urea cycle disorders, were unremarkable. Upon recurrence of symptoms with hyperammonemia, a computed tomography scan was performed which revealed a large portosystemic shunt between the splenic vein and right common iliac vein.</p><p><strong>Interventions: </strong>The patient underwent embolization of the identified portosystemic shunt.</p><p><strong>Outcomes: </strong>Following embolization of the shunt, the patient's hyperammonemia and encephalopathy resolved, with no further recurrences.</p><p><strong>Novel findings: </strong>This case illustrates the challenges of determining the etiology of hyperammonemia in patients treated with hemodialysis due to the dialysis clearance of ammonia. Portosystemic shunts cause hyperammonemia by bypassing the liver's ammonia-detoxification pathways, and their effects may be paradoxically exacerbated immediately after dialysis due to dialysis-related hemodynamic changes. We emphasize the importance of investigating hyperammonemia as a cause of altered level of consciousness among patients being treated with hemodialysis and considering anatomical shunting in the differential diagnosis.</p>","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251347154"},"PeriodicalIF":1.6000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12163263/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Kidney Health and Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20543581251347154","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale: Hyperammonemia in patients receiving hemodialysis is uncommon but poses a significant clinical challenge due to the effective clearance of ammonia by dialysis, which can obscure the underlying cause. Recognizing atypical etiologies is crucial for appropriate management.

Presenting concerns of the patient: A 59-year-old man being treated with hemodialysis presented with altered level of consciousness and recurrent hyperammonemia. Despite previous episodes of hyperammonemia, the etiology of his intermittently elevated ammonia remained unclear and was initially attributed to his kidney failure.

Diagnoses: Initial assessments, including liver function tests, abdominal ultrasound, medication review, and genetic screening for urea cycle disorders, were unremarkable. Upon recurrence of symptoms with hyperammonemia, a computed tomography scan was performed which revealed a large portosystemic shunt between the splenic vein and right common iliac vein.

Interventions: The patient underwent embolization of the identified portosystemic shunt.

Outcomes: Following embolization of the shunt, the patient's hyperammonemia and encephalopathy resolved, with no further recurrences.

Novel findings: This case illustrates the challenges of determining the etiology of hyperammonemia in patients treated with hemodialysis due to the dialysis clearance of ammonia. Portosystemic shunts cause hyperammonemia by bypassing the liver's ammonia-detoxification pathways, and their effects may be paradoxically exacerbated immediately after dialysis due to dialysis-related hemodynamic changes. We emphasize the importance of investigating hyperammonemia as a cause of altered level of consciousness among patients being treated with hemodialysis and considering anatomical shunting in the differential diagnosis.

转移诊断:血液透析掩盖高氨血症病因1例报告。
理由:高氨血症在接受血液透析的患者中并不常见,但由于透析有效清除氨,这可能使潜在的原因模糊不清,因此对临床提出了重大挑战。认识非典型病因对于适当的治疗至关重要。患者表现:一名59岁男性接受血液透析治疗,表现为意识水平改变和复发性高氨血症。尽管先前有高氨血症发作,但间歇性氨升高的病因尚不清楚,最初归因于肾功能衰竭。诊断:初步评估,包括肝功能检查、腹部超声、药物检查和尿素循环障碍的遗传筛查,均无显著差异。在高氨血症症状复发后,进行计算机断层扫描,发现脾静脉和右髂总静脉之间有一个大的门静脉系统分流。干预措施:患者对确定的门静脉系统分流进行了栓塞治疗。结果:分流栓塞后,患者的高氨血症和脑病得到缓解,没有进一步复发。新发现:这个病例说明了在血液透析治疗的患者中,由于氨的透析清除,确定高氨血症病因的挑战。门系统分流通过绕过肝脏的氨解毒途径引起高氨血症,并且由于透析相关的血流动力学改变,其影响可能在透析后立即加剧。我们强调研究高氨血症作为血液透析治疗患者意识水平改变的原因的重要性,并在鉴别诊断中考虑解剖分流。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
5.90%
发文量
84
审稿时长
12 weeks
期刊介绍: Canadian Journal of Kidney Health and Disease, the official journal of the Canadian Society of Nephrology, is an open access, peer-reviewed online journal that encourages high quality submissions focused on clinical, translational and health services delivery research in the field of chronic kidney disease, dialysis, kidney transplantation and organ donation. Our mandate is to promote and advocate for kidney health as it impacts national and international communities. Basic science, translational studies and clinical studies will be peer reviewed and processed by an Editorial Board comprised of geographically diverse Canadian and international nephrologists, internists and allied health professionals; this Editorial Board is mandated to ensure highest quality publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信